BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6158852)

  • 1. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
    Závadová Z; Závada J
    Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle.
    Závada J; Cerný L; Altstein AD; Závadová Z
    Acta Virol; 1978 Mar; 22(2):91-6. PubMed ID: 26209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid neutralization test for antibodies to bovine leukemia virus, with the use of rhabdovirus pseudotypes.
    Závada J; Cerný L; Závadová Z; Bozonová J; Altstein AD
    J Natl Cancer Inst; 1979 Jan; 62(1):95-101. PubMed ID: 214611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radioimmunoassay for internal protein of bovine leukemia virus with neutralization test employing VSV-BLV pseudotype.
    Zajac V; Altaner C; Závada J; Cerný L
    Neoplasma; 1980; 27(5):517-23. PubMed ID: 6262669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of a few methods for detecting antibodies to the bovine leukemia virus].
    Grinenko NF; Tarasishin LA; Valikhov AF; Zajac V; Al'tshteĭn AD
    Vopr Virusol; 1980; (3):281-4. PubMed ID: 6254263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus pseudotype with neutralization antigen of tick-borne encephalitis virus.
    Dragúnová J; Greśíková M
    Acta Virol; 1986 Jul; 30(4):346-8. PubMed ID: 2876617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of monoclonal antibodies directed against glycoproteins of bovine leukaemia virus.
    Orlík O; Bán J; Gieciová E; Altanerová V; Altaner C
    Acta Virol; 1993 Oct; 37(5):377-87. PubMed ID: 8184790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus phenotypically mixed with retroviruses: an efficient detection method.
    Závada J; Russ G; Závadová Z; Sabó A
    Acta Virol; 1983 Mar; 27(2):110-8. PubMed ID: 6135329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudotypes of vesicular stomatitis virus with the mixed coat of reticuloendotheliosis virus and vesicular stomatitis virus.
    Kang CY; Lambright P
    J Virol; 1977 Mar; 21(3):1252-5. PubMed ID: 191647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to vesicular stomatitis virus in cattle in an enzootic region of Mexico.
    Hernández De Anda J; Salman MD; Webb PA; Keefe TJ; Arregín Arévalo A; Mason J
    Am J Vet Res; 1992 Apr; 53(4):440-3. PubMed ID: 1316723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic determinants of vesicular stomatitis virus: analysis with antigenic variants.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Jan; 130(1):394-8. PubMed ID: 6183358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
    Mills BJ; Beebe DP; Cooper NR
    J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
    Cherney TM; Schultz RD
    Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancios L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formation of pseudotypes of VSV after culture in a human melanoma].
    Van Tieghem N; Vercammen-Grandjean A; Liteanu D; Lejeune FJ
    Ann Microbiol (Paris); 1978; 129(2):217-26. PubMed ID: 209712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus.
    Vandepol SB; Lefrancois L; Holland JJ
    Virology; 1986 Jan; 148(2):312-25. PubMed ID: 2417417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
    Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
    Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.